Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

Notch1 (mouse, recombinant; aa 19-526)

  • Zoom
    Notch1 (mouse, recombinant; aa 19-526)
  • Notch1 (mouse, recombinant; aa 19-526)
Cat No: 34633
Proteins - More Proteins
Cayman

Notch1 is a single-pass transmembrane receptor and member of the Notch family.{62466} It is synthesized as a precursor that is cleaved by a furin-like convertase to produce two subunits: the noncovalently associated extracellular (NEC) subunit, which ...

More

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Correlated keywords:
  • mT14 mT-14 Notch-1 Ala19
Product Overview:
Notch1 is a single-pass transmembrane receptor and member of the Notch family.{62466} It is synthesized as a precursor that is cleaved by a furin-like convertase to produce two subunits: the noncovalently associated extracellular (NEC) subunit, which contains 36 EGF-like repeats involved in ligand binding, and the transmembrane (NTM) subunit, which contains the transmembrane domain and several other domains that, together, act as a ligand-activated transcription factor.{62466,62467,62468} Notch1 is expressed in endothelial cells, primarily in arteries, as well as in epididymal and subcutaneous fat and the brain.{62469,62470} It is bound by ligands from the Jagged or Delta families expressed on adjacent cells, which induces a conformational change and sequential cleavage by a disintegrin and metalloproteinase domain-containing protein (ADAM) and γ-secretase, releasing the intracellular domain, which translocates to the nucleus and induces the transcription of Notch1 target genes as part of a transcriptional activation complex.{62468} Notch1 is necessary for arterial-venous differentiation during development and the maintenance of hippocampal stem cells in adulthood.{62469,62471} It is also involved in tumorigenesis, regulating cell adhesion and metastasis, and is associated with a variety of solid tumor and hematological cancers.{62472,62473} Mutations in NOTCH1 have been found in patients with chronic lymphocytic leukemia (CLL) and T cell acute lymphoblastic leukemia (T-ALL) and are associated with poor outcomes in patients with CLL.{62468} Cayman’s Notch1 (mouse, recombinant; aa 19-526) protein can be used for binding assays. This protein consists of 518 amino acids, has a calculated molecular weight of 55 kDa, and a predicted N-terminus of Ala-19 after signal peptide cleavage. By SDS-PAGE, under reducing conditions, the apparent molecular mass of the protein is 80 kDa due to glycosylation.
Size 50 µg
Shipping dry ice
Host Insect cells
Formulation Lyophilized from sterile 20 mM Tris, pH 7.4, with 500 mM sodium chloride and 10% glycerol
Purity ≥82% estimated by SDS-PAGE
Custom Code 3504.00
UNSPSC code 12352204

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

Search